

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | activated T cell proliferation (GO:0050798) | 5.33671686 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.02471418 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.02471418 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 4.53652912 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.46628237 |
| 6 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.28065831 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.19673657 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94968423 |
| 9 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.88144593 |
| 10 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.88144593 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 3.87261720 |
| 12 | kynurenine metabolic process (GO:0070189) | 3.82144431 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81329104 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 3.74810960 |
| 15 | response to interleukin-15 (GO:0070672) | 3.70011995 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68833919 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.68833919 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68833919 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.68833919 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68833919 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68833919 |
| 22 | urea cycle (GO:0000050) | 3.64368562 |
| 23 | urea metabolic process (GO:0019627) | 3.64368562 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.60609336 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.60518365 |
| 26 | regulation of memory T cell differentiation (GO:0043380) | 3.59399405 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.54017320 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.54017320 |
| 29 | lysine metabolic process (GO:0006553) | 3.51830337 |
| 30 | lysine catabolic process (GO:0006554) | 3.51830337 |
| 31 | regulation of fibrinolysis (GO:0051917) | 3.50377927 |
| 32 | linoleic acid metabolic process (GO:0043651) | 3.47178047 |
| 33 | RNA localization (GO:0006403) | 3.47124736 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45593467 |
| 35 | neutrophil activation (GO:0042119) | 3.44752303 |
| 36 | positive regulation of interferon-beta production (GO:0032728) | 3.42224286 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.42219716 |
| 38 | glyoxylate metabolic process (GO:0046487) | 3.42154361 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.41907933 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.41907933 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.41907933 |
| 42 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.36831535 |
| 43 | tryptophan metabolic process (GO:0006568) | 3.36298688 |
| 44 | cellular extravasation (GO:0045123) | 3.35955313 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.34572938 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34286323 |
| 47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.33967020 |
| 48 | macrophage differentiation (GO:0030225) | 3.30585235 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27499679 |
| 50 | detection of other organism (GO:0098543) | 3.26618604 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.25966684 |
| 52 | response to peptidoglycan (GO:0032494) | 3.25770569 |
| 53 | positive regulation of interleukin-17 production (GO:0032740) | 3.24094917 |
| 54 | phospholipid homeostasis (GO:0055091) | 3.22552255 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.22160262 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 3.18522946 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 3.17736839 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17601270 |
| 59 | detection of bacterium (GO:0016045) | 3.16147961 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 3.14284471 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.14041211 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.13249155 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.13076625 |
| 64 | protein carboxylation (GO:0018214) | 3.13076625 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11793397 |
| 66 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.10841593 |
| 67 | neutrophil mediated immunity (GO:0002446) | 3.09513333 |
| 68 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.08273928 |
| 69 | leukocyte aggregation (GO:0070486) | 3.08025117 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 3.07651236 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.06356756 |
| 72 | primary alcohol catabolic process (GO:0034310) | 3.05634781 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 3.05539994 |
| 74 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.05459103 |
| 75 | L-phenylalanine metabolic process (GO:0006558) | 3.03953505 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03953505 |
| 77 | * spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.03721589 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03232898 |
| 79 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03232898 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01341993 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 3.01141311 |
| 82 | ethanol oxidation (GO:0006069) | 3.00842763 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.00325310 |
| 84 | L-phenylalanine catabolic process (GO:0006559) | 3.00325310 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00298687 |
| 86 | granulocyte activation (GO:0036230) | 2.99118240 |
| 87 | mitochondrion distribution (GO:0048311) | 2.99008759 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 2.98995907 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 2.98993572 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98432500 |
| 91 | regulation of interferon-beta production (GO:0032648) | 2.97474545 |
| 92 | tolerance induction (GO:0002507) | 2.96969972 |
| 93 | regulation of cholesterol storage (GO:0010885) | 2.96450067 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 2.95582804 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 2.94483361 |
| 96 | positive regulation of defense response to virus by host (GO:0002230) | 2.94410683 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.94382559 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 2.94343189 |
| 99 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94044338 |
| 100 | detection of external biotic stimulus (GO:0098581) | 2.93874636 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93811162 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 2.93735960 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 2.92570665 |
| 104 | regulation of triglyceride catabolic process (GO:0010896) | 2.92221486 |
| 105 | microglial cell activation (GO:0001774) | 2.91797532 |
| 106 | type I interferon signaling pathway (GO:0060337) | 2.91604103 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.91604103 |
| 108 | detection of molecule of bacterial origin (GO:0032490) | 2.90968849 |
| 109 | response to type I interferon (GO:0034340) | 2.90848138 |
| 110 | regulation of protein activation cascade (GO:2000257) | 2.89371742 |
| 111 | retinol metabolic process (GO:0042572) | 2.88931963 |
| 112 | fatty acid oxidation (GO:0019395) | 2.88516101 |
| 113 | phospholipid efflux (GO:0033700) | 2.88224381 |
| 114 | acylglycerol homeostasis (GO:0055090) | 2.87834923 |
| 115 | triglyceride homeostasis (GO:0070328) | 2.87834923 |
| 116 | mast cell activation (GO:0045576) | 2.87042005 |
| 117 | interferon-gamma production (GO:0032609) | 2.86704930 |
| 118 | growth hormone receptor signaling pathway (GO:0060396) | 2.86110790 |
| 119 | homocysteine metabolic process (GO:0050667) | 2.85771114 |
| 120 | regulation of T cell tolerance induction (GO:0002664) | 2.85770001 |
| 121 | positive regulation of histone deacetylation (GO:0031065) | 2.85484671 |
| 122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85321736 |
| 123 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.84805636 |
| 124 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.84458794 |
| 125 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83148140 |
| 126 | positive regulation of mast cell activation (GO:0033005) | 2.82443099 |
| 127 | positive thymic T cell selection (GO:0045059) | 2.82105925 |
| 128 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.81796652 |
| 129 | regulation of tolerance induction (GO:0002643) | 2.79465534 |
| 130 | lipid oxidation (GO:0034440) | 2.78535290 |
| 131 | response to host immune response (GO:0052572) | 2.78390188 |
| 132 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78390188 |
| 133 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.77000655 |
| 134 | carnitine metabolic process (GO:0009437) | 2.76310114 |
| 135 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.75934226 |
| 136 | negative regulation of cholesterol transport (GO:0032375) | 2.75119569 |
| 137 | negative regulation of sterol transport (GO:0032372) | 2.75119569 |
| 138 | regulation of sequestering of triglyceride (GO:0010889) | 2.74564078 |
| 139 | carnitine shuttle (GO:0006853) | 2.73855060 |
| 140 | myeloid cell activation involved in immune response (GO:0002275) | 2.73218534 |
| 141 | negative regulation of lipase activity (GO:0060192) | 2.73180326 |
| 142 | regulation of cell killing (GO:0031341) | 2.72401168 |
| 143 | regulation of response to osmotic stress (GO:0047484) | 2.72172945 |
| 144 | bile acid biosynthetic process (GO:0006699) | 2.70466471 |
| 145 | regulation of germinal center formation (GO:0002634) | 2.70350054 |
| 146 | axon extension involved in axon guidance (GO:0048846) | 2.70340047 |
| 147 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.70340047 |
| 148 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.70298795 |
| 149 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.69886982 |
| 150 | regulation of complement activation (GO:0030449) | 2.68884056 |
| 151 | necrotic cell death (GO:0070265) | 2.68588234 |
| 152 | regulation of mast cell activation (GO:0033003) | 2.68438026 |
| 153 | positive regulation of antigen processing and presentation (GO:0002579) | 2.68102325 |
| 154 | detection of biotic stimulus (GO:0009595) | 2.68081788 |
| 155 | regulation of cholesterol homeostasis (GO:2000188) | 2.66635423 |
| 156 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.65822092 |
| 157 | myeloid leukocyte mediated immunity (GO:0002444) | 2.65708483 |
| 158 | hormone catabolic process (GO:0042447) | 2.65605868 |
| 159 | T cell migration (GO:0072678) | 2.64868362 |
| 160 | response to interferon-beta (GO:0035456) | 2.64659815 |
| 161 | protein-lipid complex assembly (GO:0065005) | 2.64110665 |
| 162 | T cell selection (GO:0045058) | 2.63805924 |
| 163 | positive regulation of cell killing (GO:0031343) | 2.63283666 |
| 164 | regulation of interleukin-17 production (GO:0032660) | 2.63004627 |
| 165 | necroptotic process (GO:0070266) | 2.61638227 |
| 166 | programmed necrotic cell death (GO:0097300) | 2.60935862 |
| 167 | ethanol metabolic process (GO:0006067) | 2.59609518 |
| 168 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.59247625 |
| 169 | plasma lipoprotein particle assembly (GO:0034377) | 2.56352872 |
| 170 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.55387392 |
| 171 | plasma lipoprotein particle remodeling (GO:0034369) | 2.52878198 |
| 172 | protein-lipid complex remodeling (GO:0034368) | 2.52878198 |
| 173 | macromolecular complex remodeling (GO:0034367) | 2.52878198 |
| 174 | sulfur amino acid catabolic process (GO:0000098) | 2.45404148 |
| 175 | blood vessel endothelial cell migration (GO:0043534) | 2.44778452 |
| 176 | fatty acid catabolic process (GO:0009062) | 2.44564146 |
| 177 | monocarboxylic acid catabolic process (GO:0072329) | 2.44526773 |
| 178 | valine metabolic process (GO:0006573) | 2.43977262 |
| 179 | primary alcohol metabolic process (GO:0034308) | 2.43799814 |
| 180 | sodium-independent organic anion transport (GO:0043252) | 2.43618358 |
| 181 | positive regulation of lipid storage (GO:0010884) | 2.42277312 |
| 182 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.41974782 |
| 183 | negative thymic T cell selection (GO:0045060) | 2.40956020 |
| 184 | carnitine transmembrane transport (GO:1902603) | 2.40161601 |
| 185 | positive T cell selection (GO:0043368) | 2.40031067 |
| 186 | positive regulation of lipid catabolic process (GO:0050996) | 2.39946769 |
| 187 | fibrinolysis (GO:0042730) | 2.39704288 |
| 188 | negative T cell selection (GO:0043383) | 2.38361181 |
| 189 | regulation of fatty acid oxidation (GO:0046320) | 2.38333269 |
| 190 | cholesterol efflux (GO:0033344) | 2.38207153 |
| 191 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.38077792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.73621871 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.11843348 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.05802090 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.77628261 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.77463980 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49761222 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.33746759 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90083220 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81602055 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77553598 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.73300033 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.72056374 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60118579 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.38334426 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20307073 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.13090010 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97829361 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.94283540 |
| 19 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90803713 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88495569 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85098368 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84565994 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81756626 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81583677 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81260255 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.76063856 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75718009 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75291881 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74203587 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.72509781 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69936724 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.69475060 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67756490 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66258461 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63673447 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62585053 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61379908 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57448380 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56868423 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54980099 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54133189 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53883554 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52286797 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51979057 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47599033 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45305057 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.44597129 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.44597129 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44138024 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43347734 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42560271 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40894272 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40093659 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39902247 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39176450 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37153892 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36749861 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36353410 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36184429 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36076379 |
| 61 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35229799 |
| 62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35088508 |
| 63 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34053492 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33307078 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30590235 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27829259 |
| 67 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.27555720 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26181522 |
| 69 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26151944 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25832710 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25174643 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25024349 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22629373 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22005185 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21850030 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21039416 |
| 77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19859139 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19316640 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18711417 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16353724 |
| 81 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14597732 |
| 82 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13833103 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12252444 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11558225 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11437036 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10798674 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10111893 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09922409 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09360465 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08909313 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08193723 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.05558266 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04628225 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04137703 |
| 95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03807396 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 1.03621848 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03004584 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01797540 |
| 99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00972859 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00972859 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00894013 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.00488331 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00402826 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00372757 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99998758 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99964284 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99964284 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99662009 |
| 109 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99617426 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98933863 |
| 111 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98740437 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97492635 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97466184 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96968704 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96938316 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96762096 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95919367 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95897774 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95629285 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95441430 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95139919 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95077462 |
| 123 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94718806 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94606087 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93698331 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93120789 |
| 127 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93075949 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93061470 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92926005 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92174972 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90717797 |
| 132 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90428616 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90408443 |
| 134 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89424179 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89348794 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88394048 |
| 137 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87421969 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87394265 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87278987 |
| 140 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.86900836 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86636008 |
| 142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86595022 |
| 143 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83406846 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83378269 |
| 145 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83227848 |
| 146 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82541326 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82394743 |
| 148 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82017043 |
| 149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81682524 |
| 150 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80469742 |
| 151 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80032100 |
| 152 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.79340267 |
| 153 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79297464 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79016620 |
| 155 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78546112 |
| 156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78464800 |
| 157 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77306928 |
| 158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77103241 |
| 159 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76401692 |
| 160 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75747365 |
| 161 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74837828 |
| 162 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74559261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.95005846 |
| 2 | MP0003724_increased_susceptibility_to | 3.91418962 |
| 3 | MP0005671_abnormal_response_to | 3.86559852 |
| 4 | MP0005360_urolithiasis | 3.80775999 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.74659839 |
| 6 | MP0005365_abnormal_bile_salt | 3.22971616 |
| 7 | MP0009785_altered_susceptibility_to | 2.96889871 |
| 8 | MP0005670_abnormal_white_adipose | 2.79014309 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.74086971 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.67176757 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.64991639 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.55590564 |
| 13 | MP0003252_abnormal_bile_duct | 2.54610036 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.48909948 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.43989098 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.43760375 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.41928832 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.41757318 |
| 19 | MP0001958_emphysema | 2.32174527 |
| 20 | MP0002405_respiratory_system_inflammati | 2.01318946 |
| 21 | MP0009278_abnormal_bone_marrow | 1.91952734 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.88272668 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.86730770 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.80958325 |
| 25 | MP0000716_abnormal_immune_system | 1.78703156 |
| 26 | MP0006082_CNS_inflammation | 1.76601775 |
| 27 | MP0003880_abnormal_central_pattern | 1.75680651 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.75190623 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.70920326 |
| 30 | MP0000609_abnormal_liver_physiology | 1.68765843 |
| 31 | MP0003866_abnormal_defecation | 1.65274597 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63522135 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.62274142 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.59807974 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.57429939 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.55489464 |
| 37 | MP0001851_eye_inflammation | 1.48155428 |
| 38 | MP0002722_abnormal_immune_system | 1.47630973 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.46867597 |
| 40 | MP0005083_abnormal_biliary_tract | 1.41580273 |
| 41 | MP0002971_abnormal_brown_adipose | 1.40081005 |
| 42 | MP0009840_abnormal_foam_cell | 1.40025318 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.39326555 |
| 44 | MP0004381_abnormal_hair_follicle | 1.38866205 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.37304090 |
| 46 | MP0000371_diluted_coat_color | 1.37149684 |
| 47 | MP0005451_abnormal_body_composition | 1.35803016 |
| 48 | MP0005310_abnormal_salivary_gland | 1.35765914 |
| 49 | MP0005501_abnormal_skin_physiology | 1.35642386 |
| 50 | MP0002429_abnormal_blood_cell | 1.35288230 |
| 51 | MP0004947_skin_inflammation | 1.33484742 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.33175201 |
| 53 | MP0003436_decreased_susceptibility_to | 1.32379442 |
| 54 | MP0003828_pulmonary_edema | 1.31955434 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.30058550 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.29271365 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.29000687 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.27135230 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.26483694 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.25998525 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.24522050 |
| 62 | MP0003303_peritoneal_inflammation | 1.23143050 |
| 63 | MP0009115_abnormal_fat_cell | 1.22938614 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.20483443 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.20483443 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.18661199 |
| 67 | MP0003878_abnormal_ear_physiology | 1.15989054 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.15989054 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.14680031 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.12303430 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 1.11187091 |
| 72 | MP0001800_abnormal_humoral_immune | 1.10644748 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.10158416 |
| 74 | MP0010630_abnormal_cardiac_muscle | 1.09517284 |
| 75 | MP0002796_impaired_skin_barrier | 1.09048632 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.08683059 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.08679797 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.06078249 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.05983071 |
| 80 | MP0010307_abnormal_tumor_latency | 1.04684514 |
| 81 | MP0005334_abnormal_fat_pad | 1.04330118 |
| 82 | MP0000598_abnormal_liver_morphology | 1.02759743 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.02634927 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.02422154 |
| 85 | MP0003045_fibrosis | 1.00984038 |
| 86 | MP0001915_intracranial_hemorrhage | 1.00858990 |
| 87 | MP0002168_other_aberrant_phenotype | 0.99418452 |
| 88 | MP0009764_decreased_sensitivity_to | 0.99020897 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.98717485 |
| 90 | MP0005332_abnormal_amino_acid | 0.96886429 |
| 91 | MP0005387_immune_system_phenotype | 0.96187646 |
| 92 | MP0001790_abnormal_immune_system | 0.96187646 |
| 93 | MP0002132_abnormal_respiratory_system | 0.94751661 |
| 94 | MP0008260_abnormal_autophagy | 0.94462166 |
| 95 | MP0002970_abnormal_white_adipose | 0.94128482 |
| 96 | MP0003279_aneurysm | 0.93645726 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.92283047 |
| 98 | MP0002933_joint_inflammation | 0.91692909 |
| 99 | MP0004883_abnormal_blood_vessel | 0.90658309 |
| 100 | MP0001835_abnormal_antigen_presentation | 0.90632704 |
| 101 | MP0004130_abnormal_muscle_cell | 0.90491575 |
| 102 | MP0005330_cardiomyopathy | 0.90312270 |
| 103 | MP0005275_abnormal_skin_tensile | 0.89880626 |
| 104 | MP0000604_amyloidosis | 0.89492932 |
| 105 | MP0001191_abnormal_skin_condition | 0.89296706 |
| 106 | MP0009763_increased_sensitivity_to | 0.88876186 |
| 107 | MP0004885_abnormal_endolymph | 0.88815413 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.86518239 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.84456059 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.84314728 |
| 111 | MP0004087_abnormal_muscle_fiber | 0.84017760 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.83906031 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.83821246 |
| 114 | MP0002928_abnormal_bile_duct | 0.83820320 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.83709687 |
| 116 | MP0005025_abnormal_response_to | 0.83212977 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.81434371 |
| 118 | MP0000685_abnormal_immune_system | 0.81148875 |
| 119 | MP0002128_abnormal_blood_circulation | 0.80934803 |
| 120 | MP0000377_abnormal_hair_follicle | 0.80856906 |
| 121 | MP0002254_reproductive_system_inflammat | 0.80756281 |
| 122 | MP0002060_abnormal_skin_morphology | 0.80448024 |
| 123 | MP0000343_altered_response_to | 0.79569244 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79312789 |
| 125 | MP0008469_abnormal_protein_level | 0.78785398 |
| 126 | MP0003195_calcinosis | 0.77082518 |
| 127 | MP0002420_abnormal_adaptive_immunity | 0.76895901 |
| 128 | MP0001663_abnormal_digestive_system | 0.76846541 |
| 129 | MP0002398_abnormal_bone_marrow | 0.76388005 |
| 130 | MP0009053_abnormal_anal_canal | 0.75014640 |
| 131 | MP0001764_abnormal_homeostasis | 0.74809241 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.74502813 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.74491569 |
| 134 | MP0009672_abnormal_birth_weight | 0.73920021 |
| 135 | MP0000858_altered_metastatic_potential | 0.73864401 |
| 136 | MP0001819_abnormal_immune_cell | 0.73635483 |
| 137 | MP0010352_gastrointestinal_tract_polyps | 0.73379827 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.72540634 |
| 139 | MP0000249_abnormal_blood_vessel | 0.71832446 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.71021472 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.70471530 |
| 142 | MP0005023_abnormal_wound_healing | 0.69399576 |
| 143 | MP0005164_abnormal_response_to | 0.68952752 |
| 144 | MP0002735_abnormal_chemical_nociception | 0.68940481 |
| 145 | MP0009931_abnormal_skin_appearance | 0.68890316 |
| 146 | MP0004484_altered_response_of | 0.68802003 |
| 147 | MP0002419_abnormal_innate_immunity | 0.68342311 |
| 148 | MP0002396_abnormal_hematopoietic_system | 0.68241889 |
| 149 | MP0002078_abnormal_glucose_homeostasis | 0.68212592 |
| 150 | MP0002653_abnormal_ependyma_morphology | 0.68024282 |
| 151 | MP0010234_abnormal_vibrissa_follicle | 0.67986929 |
| 152 | MP0000372_irregular_coat_pigmentation | 0.67801896 |
| 153 | MP0002006_tumorigenesis | 0.67106749 |
| 154 | MP0001873_stomach_inflammation | 0.67027546 |
| 155 | MP0002723_abnormal_immune_serum | 0.66898684 |
| 156 | MP0001849_ear_inflammation | 0.66070255 |
| 157 | MP0005248_abnormal_Harderian_gland | 0.66062479 |
| 158 | MP0001845_abnormal_inflammatory_respons | 0.65684299 |
| 159 | MP0005390_skeleton_phenotype | 0.65445513 |
| 160 | MP0001968_abnormal_touch/_nociception | 0.63980031 |
| 161 | MP0001853_heart_inflammation | 0.63575827 |
| 162 | MP0002095_abnormal_skin_pigmentation | 0.62898794 |
| 163 | MP0008872_abnormal_physiological_respon | 0.60128892 |
| 164 | MP0004742_abnormal_vestibular_system | 0.59751555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 5.98785648 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.98785648 |
| 3 | Myositis (HP:0100614) | 5.74900745 |
| 4 | Orchitis (HP:0100796) | 5.64764501 |
| 5 | Stomatitis (HP:0010280) | 4.66506296 |
| 6 | Hypoalphalipoproteinemia (HP:0003233) | 4.56235165 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.39712573 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.28433764 |
| 9 | Keratoconjunctivitis (HP:0001096) | 4.16483419 |
| 10 | Renovascular hypertension (HP:0100817) | 4.11294591 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.94747812 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.94747812 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.90685078 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82587546 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.81579423 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.76674050 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.76520353 |
| 18 | Encephalitis (HP:0002383) | 3.66319664 |
| 19 | Vascular calcification (HP:0004934) | 3.66001540 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.52103477 |
| 21 | Pulmonary infiltrates (HP:0002113) | 3.51410230 |
| 22 | Vasculitis (HP:0002633) | 3.49594286 |
| 23 | Cardiovascular calcification (HP:0011915) | 3.44917434 |
| 24 | Hemoptysis (HP:0002105) | 3.40196398 |
| 25 | Increased IgM level (HP:0003496) | 3.36007610 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.33181385 |
| 27 | T lymphocytopenia (HP:0005403) | 3.20552174 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19288358 |
| 29 | Meningitis (HP:0001287) | 3.18496001 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14901848 |
| 31 | Recurrent skin infections (HP:0001581) | 3.12135365 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09163726 |
| 33 | Joint hemorrhage (HP:0005261) | 3.01295595 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.00166257 |
| 35 | Mitral stenosis (HP:0001718) | 2.94285484 |
| 36 | Progressive inability to walk (HP:0002505) | 2.93673733 |
| 37 | IgG deficiency (HP:0004315) | 2.91256871 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.88150519 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.87642691 |
| 40 | Abnormality of T cells (HP:0002843) | 2.84097808 |
| 41 | Abnormality of eosinophils (HP:0001879) | 2.81228908 |
| 42 | Leukocytosis (HP:0001974) | 2.80237069 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.79333525 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.77148091 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.74822510 |
| 46 | Eosinophilia (HP:0001880) | 2.74227248 |
| 47 | Hip dysplasia (HP:0001385) | 2.73686212 |
| 48 | Pustule (HP:0200039) | 2.70699006 |
| 49 | Urticaria (HP:0001025) | 2.69145976 |
| 50 | Granulocytopenia (HP:0001913) | 2.66813541 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64934119 |
| 52 | Anorexia (HP:0002039) | 2.64615695 |
| 53 | Xanthomatosis (HP:0000991) | 2.59963159 |
| 54 | Arterial thrombosis (HP:0004420) | 2.59721631 |
| 55 | Complement deficiency (HP:0004431) | 2.59195640 |
| 56 | Hyperacusis (HP:0010780) | 2.57902922 |
| 57 | Stomach cancer (HP:0012126) | 2.56597699 |
| 58 | Chronic hepatic failure (HP:0100626) | 2.52911529 |
| 59 | Ketosis (HP:0001946) | 2.52119690 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.48462880 |
| 61 | Hand muscle atrophy (HP:0009130) | 2.47511725 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.47449122 |
| 63 | Frequent falls (HP:0002359) | 2.47113159 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.46896247 |
| 65 | Subcapsular cataract (HP:0000523) | 2.46425707 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.46225219 |
| 67 | Gingivitis (HP:0000230) | 2.46125066 |
| 68 | Myoglobinuria (HP:0002913) | 2.46058624 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.44161170 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.43606867 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.43598410 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.43022256 |
| 73 | Myocardial infarction (HP:0001658) | 2.41179954 |
| 74 | Hypoglycemic coma (HP:0001325) | 2.41113847 |
| 75 | Hypobetalipoproteinemia (HP:0003563) | 2.40850138 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.39937220 |
| 77 | Elfin facies (HP:0004428) | 2.38479729 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 2.37968475 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37517620 |
| 80 | Polyneuropathy (HP:0001271) | 2.35747565 |
| 81 | Keratitis (HP:0000491) | 2.35338290 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.33731452 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.33254093 |
| 84 | Aortic aneurysm (HP:0004942) | 2.32781496 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.32383465 |
| 86 | Chronic otitis media (HP:0000389) | 2.32238259 |
| 87 | Hyperlipoproteinemia (HP:0010980) | 2.32046977 |
| 88 | Cone-rod dystrophy (HP:0000548) | 2.31254425 |
| 89 | Gangrene (HP:0100758) | 2.31161816 |
| 90 | Pulmonary embolism (HP:0002204) | 2.29141630 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.28569743 |
| 92 | Cerebral aneurysm (HP:0004944) | 2.27816376 |
| 93 | Hypochromic anemia (HP:0001931) | 2.26299317 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.25256110 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.22602306 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 2.19928426 |
| 97 | Abnormality of the fingertips (HP:0001211) | 2.19907137 |
| 98 | Epidermoid cyst (HP:0200040) | 2.18827010 |
| 99 | Chest pain (HP:0100749) | 2.17089155 |
| 100 | Lymphopenia (HP:0001888) | 2.13567571 |
| 101 | Recurrent viral infections (HP:0004429) | 2.12402105 |
| 102 | Obstructive lung disease (HP:0006536) | 2.12263645 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12263645 |
| 104 | Inability to walk (HP:0002540) | 2.11784688 |
| 105 | Abnormality of complement system (HP:0005339) | 2.10033362 |
| 106 | Poikilocytosis (HP:0004447) | 2.09239577 |
| 107 | Spinal muscular atrophy (HP:0007269) | 2.08826387 |
| 108 | Cardiomegaly (HP:0001640) | 2.06135814 |
| 109 | Albinism (HP:0001022) | 2.05878676 |
| 110 | Nephrocalcinosis (HP:0000121) | 2.05695358 |
| 111 | Nasal polyposis (HP:0100582) | 2.05554272 |
| 112 | Tubulointerstitial nephritis (HP:0001970) | 2.04141172 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.03852677 |
| 114 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.03522650 |
| 115 | Spontaneous hematomas (HP:0007420) | 2.03510188 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 2.02876829 |
| 117 | Hypertriglyceridemia (HP:0002155) | 2.01020850 |
| 118 | Epistaxis (HP:0000421) | 2.00826556 |
| 119 | Aneurysm (HP:0002617) | 1.99372855 |
| 120 | Periodontitis (HP:0000704) | 1.98891691 |
| 121 | Ketoacidosis (HP:0001993) | 1.97911729 |
| 122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96607328 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 1.95481531 |
| 124 | Hyperammonemia (HP:0001987) | 1.95084595 |
| 125 | Vertigo (HP:0002321) | 1.94687462 |
| 126 | Generalized aminoaciduria (HP:0002909) | 1.94666476 |
| 127 | Renal cortical cysts (HP:0000803) | 1.94345686 |
| 128 | True hermaphroditism (HP:0010459) | 1.93163726 |
| 129 | Episodic fever (HP:0001954) | 1.92781242 |
| 130 | Neonatal death (HP:0003811) | 1.92768833 |
| 131 | Abnormality of the vocal cords (HP:0008777) | 1.92710142 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.92638856 |
| 133 | Hepatitis (HP:0012115) | 1.92346576 |
| 134 | Congenital stationary night blindness (HP:0007642) | 1.91219266 |
| 135 | Hyperglycinuria (HP:0003108) | 1.90825636 |
| 136 | Lymphangioma (HP:0100764) | 1.90571067 |
| 137 | Cholelithiasis (HP:0001081) | 1.90367339 |
| 138 | Thyroiditis (HP:0100646) | 1.90318369 |
| 139 | Esophageal varix (HP:0002040) | 1.88781819 |
| 140 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87973374 |
| 141 | Papilledema (HP:0001085) | 1.87875375 |
| 142 | Long toe (HP:0010511) | 1.87861756 |
| 143 | Heterotopia (HP:0002282) | 1.87705257 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.86361444 |
| 145 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85118074 |
| 146 | Nephritis (HP:0000123) | 1.84852195 |
| 147 | Ventricular tachycardia (HP:0004756) | 1.84496808 |
| 148 | Glomerulopathy (HP:0100820) | 1.84045909 |
| 149 | Hepatocellular carcinoma (HP:0001402) | 1.83373277 |
| 150 | Abnormality of B cell number (HP:0010975) | 1.82734327 |
| 151 | Inflammation of the large intestine (HP:0002037) | 1.82680785 |
| 152 | Recurrent sinusitis (HP:0011108) | 1.82190570 |
| 153 | Joint swelling (HP:0001386) | 1.81292661 |
| 154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80648434 |
| 155 | Absent frontal sinuses (HP:0002688) | 1.79947661 |
| 156 | Abnormality of the pericardium (HP:0001697) | 1.79751592 |
| 157 | Abnormality of midbrain morphology (HP:0002418) | 1.79050229 |
| 158 | Molar tooth sign on MRI (HP:0002419) | 1.79050229 |
| 159 | Hyperventilation (HP:0002883) | 1.78607507 |
| 160 | Increased IgE level (HP:0003212) | 1.78202761 |
| 161 | Increased cerebral lipofuscin (HP:0011813) | 1.77050640 |
| 162 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76762592 |
| 163 | Increased CSF protein (HP:0002922) | 1.76705361 |
| 164 | Polycythemia (HP:0001901) | 1.75879780 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.74468065 |
| 166 | Pancreatic cysts (HP:0001737) | 1.74056861 |
| 167 | Chronic diarrhea (HP:0002028) | 1.73825857 |
| 168 | Hypoproteinemia (HP:0003075) | 1.73777462 |
| 169 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73504401 |
| 170 | Peritonitis (HP:0002586) | 1.72997636 |
| 171 | Portal hypertension (HP:0001409) | 1.72973484 |
| 172 | Microcytic anemia (HP:0001935) | 1.72692030 |
| 173 | Progressive sensorineural hearing impairment (HP:0000408) | 1.72302886 |
| 174 | Abnormality of the peritoneum (HP:0002585) | 1.72283177 |
| 175 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70477083 |
| 176 | Bowel diverticulosis (HP:0005222) | 1.68547704 |
| 177 | Abnormal platelet volume (HP:0011876) | 1.68012981 |
| 178 | Short 4th metacarpal (HP:0010044) | 1.66363576 |
| 179 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.66363576 |
| 180 | Abnormality of purine metabolism (HP:0004352) | 1.66269915 |
| 181 | Cortical dysplasia (HP:0002539) | 1.65794601 |
| 182 | Obsessive-compulsive behavior (HP:0000722) | 1.65129624 |
| 183 | Abnormal gallbladder morphology (HP:0012437) | 1.63297712 |
| 184 | Bladder diverticulum (HP:0000015) | 1.61690703 |
| 185 | Reticulocytosis (HP:0001923) | 1.61665465 |
| 186 | Truncal obesity (HP:0001956) | 1.61178921 |
| 187 | Exercise-induced myalgia (HP:0003738) | 1.59368724 |
| 188 | High pitched voice (HP:0001620) | 1.58677675 |
| 189 | Overriding aorta (HP:0002623) | 1.58434475 |
| 190 | Hemorrhage of the eye (HP:0011885) | 1.57972638 |
| 191 | Hyperphosphatemia (HP:0002905) | 1.56762988 |
| 192 | Acanthosis nigricans (HP:0000956) | 1.56369217 |
| 193 | Gingival bleeding (HP:0000225) | 1.56081022 |
| 194 | Acanthocytosis (HP:0001927) | 1.55635168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.17193975 |
| 2 | FES | 3.57109989 |
| 3 | MAP3K10 | 3.36049697 |
| 4 | FGFR4 | 3.24733122 |
| 5 | PTK6 | 3.09550058 |
| 6 | PKN2 | 3.08151378 |
| 7 | TRIB3 | 3.04484268 |
| 8 | RIPK4 | 2.92885767 |
| 9 | CDK12 | 2.31301699 |
| 10 | ERN1 | 2.23578527 |
| 11 | SIK3 | 2.23290878 |
| 12 | TTN | 2.19988857 |
| 13 | MAP4K1 | 2.11519453 |
| 14 | SIK1 | 2.03305114 |
| 15 | FRK | 2.00674526 |
| 16 | VRK1 | 1.87948723 |
| 17 | TNK2 | 1.85962720 |
| 18 | PRPF4B | 1.80734055 |
| 19 | TAOK3 | 1.76927267 |
| 20 | INSRR | 1.70633217 |
| 21 | TESK1 | 1.64251878 |
| 22 | TNIK | 1.63299095 |
| 23 | WNK3 | 1.58494055 |
| 24 | STK10 | 1.56445343 |
| 25 | JAK1 | 1.49663352 |
| 26 | IRAK4 | 1.49478117 |
| 27 | ADRBK2 | 1.48166685 |
| 28 | TYK2 | 1.47751338 |
| 29 | FGFR3 | 1.46166260 |
| 30 | LYN | 1.44056005 |
| 31 | MAPKAPK3 | 1.34468750 |
| 32 | NEK9 | 1.34056479 |
| 33 | TEC | 1.33534383 |
| 34 | JAK3 | 1.32035461 |
| 35 | NLK | 1.28938595 |
| 36 | RIPK1 | 1.27258556 |
| 37 | FGFR2 | 1.19336538 |
| 38 | LATS1 | 1.19279941 |
| 39 | SGK3 | 1.18963178 |
| 40 | MAP2K6 | 1.18842005 |
| 41 | IKBKB | 1.18518297 |
| 42 | ZAP70 | 1.18368338 |
| 43 | TRPM7 | 1.14840893 |
| 44 | RET | 1.12622554 |
| 45 | ITK | 1.11286471 |
| 46 | HCK | 1.11166160 |
| 47 | IRAK1 | 1.08108448 |
| 48 | BCKDK | 1.05807447 |
| 49 | MAP2K3 | 1.05461546 |
| 50 | TGFBR2 | 1.05088329 |
| 51 | TXK | 1.04364331 |
| 52 | MARK3 | 1.01928256 |
| 53 | TYRO3 | 1.01611379 |
| 54 | PRKD2 | 0.99283512 |
| 55 | TRIM28 | 0.98730816 |
| 56 | MAPK7 | 0.97494224 |
| 57 | ZAK | 0.97308231 |
| 58 | SGK2 | 0.95636249 |
| 59 | CAMK1D | 0.94055155 |
| 60 | LRRK2 | 0.93606622 |
| 61 | PDGFRA | 0.93449291 |
| 62 | CLK1 | 0.92102335 |
| 63 | SIK2 | 0.91862659 |
| 64 | EPHA3 | 0.90919052 |
| 65 | JAK2 | 0.88764901 |
| 66 | BMPR2 | 0.88370688 |
| 67 | MAPK11 | 0.87675301 |
| 68 | PIK3CG | 0.87496708 |
| 69 | PRKCH | 0.86914527 |
| 70 | RPS6KB2 | 0.86603315 |
| 71 | EPHB2 | 0.86245604 |
| 72 | MTOR | 0.85723347 |
| 73 | FGR | 0.85606051 |
| 74 | STK38 | 0.85448995 |
| 75 | PDK4 | 0.85220281 |
| 76 | PDK3 | 0.85220281 |
| 77 | MATK | 0.84476864 |
| 78 | BTK | 0.84453712 |
| 79 | OXSR1 | 0.84099757 |
| 80 | ACVR1B | 0.84094325 |
| 81 | BLK | 0.84071526 |
| 82 | MAPK13 | 0.83354340 |
| 83 | FGFR1 | 0.81174471 |
| 84 | PIK3CA | 0.79334940 |
| 85 | ICK | 0.79021343 |
| 86 | TLK1 | 0.78609961 |
| 87 | MAP4K2 | 0.77759174 |
| 88 | CAMK1G | 0.77467181 |
| 89 | FLT3 | 0.76922528 |
| 90 | PRKCQ | 0.76041808 |
| 91 | PTK2B | 0.75805343 |
| 92 | KIT | 0.75581710 |
| 93 | DAPK2 | 0.73281696 |
| 94 | PRKD3 | 0.72856822 |
| 95 | KDR | 0.72048786 |
| 96 | PIM1 | 0.71750021 |
| 97 | STK11 | 0.71521543 |
| 98 | NUAK1 | 0.69816435 |
| 99 | MAP3K7 | 0.67752051 |
| 100 | SYK | 0.66064892 |
| 101 | CSK | 0.64121730 |
| 102 | PRKAA1 | 0.63066239 |
| 103 | MAP3K5 | 0.62751071 |
| 104 | TTK | 0.62658918 |
| 105 | CAMKK2 | 0.62553506 |
| 106 | PASK | 0.61125163 |
| 107 | IRAK3 | 0.60619662 |
| 108 | MAP3K1 | 0.60611943 |
| 109 | PDGFRB | 0.60118279 |
| 110 | ADRBK1 | 0.60063359 |
| 111 | MARK1 | 0.59510813 |
| 112 | PTK2 | 0.59177707 |
| 113 | CDC42BPA | 0.58998898 |
| 114 | MAPK12 | 0.58606448 |
| 115 | RPS6KA2 | 0.58097453 |
| 116 | BCR | 0.58007655 |
| 117 | PRKAA2 | 0.57310526 |
| 118 | TGFBR1 | 0.56640348 |
| 119 | CDK9 | 0.56391735 |
| 120 | DYRK1B | 0.56271790 |
| 121 | TAOK1 | 0.55721105 |
| 122 | PRKCE | 0.54803855 |
| 123 | HIPK2 | 0.54703148 |
| 124 | RPS6KB1 | 0.54628027 |
| 125 | BMX | 0.53349103 |
| 126 | CCNB1 | 0.53346175 |
| 127 | YES1 | 0.52239476 |
| 128 | EPHB1 | 0.51598776 |
| 129 | CDK6 | 0.50426606 |
| 130 | MELK | 0.50237049 |
| 131 | LCK | 0.50005674 |
| 132 | FER | 0.49423240 |
| 133 | MARK2 | 0.49278982 |
| 134 | GRK7 | 0.49215201 |
| 135 | PRKD1 | 0.49016756 |
| 136 | MAP3K3 | 0.47948276 |
| 137 | MAP3K13 | 0.47439259 |
| 138 | TBK1 | 0.47323352 |
| 139 | CDK4 | 0.46933989 |
| 140 | MAP3K14 | 0.46185112 |
| 141 | IKBKE | 0.45394491 |
| 142 | PDK1 | 0.45391184 |
| 143 | CAMKK1 | 0.45153673 |
| 144 | FYN | 0.43312109 |
| 145 | STK38L | 0.42219686 |
| 146 | BRD4 | 0.41970604 |
| 147 | ABL1 | 0.39846380 |
| 148 | STK3 | 0.39614752 |
| 149 | ATR | 0.39367753 |
| 150 | BMPR1B | 0.38917910 |
| 151 | CHUK | 0.37880330 |
| 152 | CAMK4 | 0.37710367 |
| 153 | GRK6 | 0.37547882 |
| 154 | CSF1R | 0.37141048 |
| 155 | GRK1 | 0.36091418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95973569 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84891919 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.84545012 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.72213202 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.47735758 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.27318661 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26946744 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26670381 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.25156811 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.23803088 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23434178 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21512446 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 2.15952333 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06858639 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05167189 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03438840 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00291958 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99289486 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99254783 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.98293709 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88330115 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.87423642 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87314587 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81165618 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78052135 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.77666850 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76306199 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75098672 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.74118845 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.67804827 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65868829 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55539554 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55129440 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.41333256 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.39469168 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.39018905 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38336171 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36149274 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36124145 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35729204 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35003988 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33387020 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.33240434 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.31329486 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.30969874 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.29913823 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.25947742 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25443675 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25222688 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.22599519 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20165988 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19992891 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18913097 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.14946966 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11699758 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.11597401 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10803331 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07898521 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06965701 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06479883 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05850845 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03570721 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02502139 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.01428325 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00869662 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98895241 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97494244 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97335810 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97035462 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96981754 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96577382 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95531027 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.95362755 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95069830 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90592141 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90364385 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90011485 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89795148 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89583185 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.87229971 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86749506 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86394547 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85391490 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81610769 |
| 85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81595752 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81235990 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78459499 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77879878 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77682183 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76928753 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76918988 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75795788 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75453773 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75357034 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75281485 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.74291411 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72720696 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72586244 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72219885 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71435865 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70547445 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70344625 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.69297205 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69048112 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68313582 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68304207 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.68270191 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67321390 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67282533 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67050918 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66574798 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65623556 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65496452 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65442275 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63989260 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62528327 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62427320 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.58939677 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58482493 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58159028 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57165743 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57160217 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.56456742 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.56237625 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56114959 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55119358 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54837078 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54674557 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54283050 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53562121 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52609127 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52186410 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52073917 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52062144 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52031799 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51686670 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51166492 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50463721 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49917419 |
| 140 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49783834 |
| 141 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49527944 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49459003 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49001573 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48768654 |
| 145 | Focal adhesion_Homo sapiens_hsa04510 | 0.47598426 |
| 146 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47228722 |
| 147 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46503649 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46258668 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46056293 |
| 150 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45029294 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44881003 |
| 152 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44846227 |
| 153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44228795 |
| 154 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44016974 |
| 155 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43009910 |
| 156 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42657354 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42302579 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42247696 |
| 159 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41345321 |
| 160 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40938496 |
| 161 | Salmonella infection_Homo sapiens_hsa05132 | 0.40892727 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | 0.40494235 |
| 163 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39409077 |
| 164 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38521506 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36314223 |
| 166 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35847225 |
| 167 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35650826 |
| 168 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35607689 |
| 169 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33462768 |
| 170 | Endocytosis_Homo sapiens_hsa04144 | 0.32840096 |
| 171 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32517569 |

